Skip to main content
. 2017 Feb 22;2017:3414910. doi: 10.1155/2017/3414910

Table 2.

CTC positivity (number of cases and percentage) by AdnaTest stratified according to clinical settings and time of analysis.

Clinical setting CTC+ (%) at baseline
(T0)
CTC+ (%) after the 1st cycle of therapy
(T1)
CTC+ (%) after the 2nd cycle of therapy
(T2)
M 0 4/16 (25.0%) 9/15 (60.0%) 10/16 (62.5%)
M + 27/47 (57.4%) 32/37 (86.5%) 16/25 (64.0%)
M1 18/33 (54.6%) 21/26 (80.8%) 16/25 (64.0%)
M2 9/14 (64.3%) 11/11 (100%)
Total 31/63 (49.2%) 41/52 (78.8%) 26/41 (63.4%)